The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
Liquid ready-to-use
100% human Plasma
Quarterly reporting (3 samples per quarterly distribution)
Submit results and view reports online via RIQAS.Net
Suitable for both quantitative and qualitative methods of analysis
Not accredited to ISO/IEC 17043
Parameters
Anti-EBNA IgG, Anti-EBV VCA IgG and Anti-EBV VCA IgGM"